Latest KFF Health News Stories
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Stephanie Armour of The Wall Street Journal and Rebecca Adams of CQ Roll Call discuss how Medicare, Medicaid and the fate of the Affordable Care Act are playing out in the politics of the coming midterm elections. Plus, Rovner interviews Matt Eyles, president and CEO of America’s Health Insurance Plans.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Sarah Kliff of Vox.com, Anna Edney of Bloomberg News and Alice Ollstein of Talking Points Memo discuss the collapse of the nomination of White House physician Ronny Jackson to head the Department of Veterans Affairs. They also discuss new bipartisan congressional efforts to address the opioid epidemic. Plus, for extra credit, the panelists offer their favorite health policy stories of the week.
Even though voters in Maine decided to expand Medicaid through a ballot measure, the law’s fate is still unclear. Gov. Paul LePage says the Legislature must find funds for it without raising taxes. Advocates say the law is on their side and expansion must be implemented.
A battle brews as Republican Gov. Paul LePage says he won’t implement the Medicaid expansion unless the Legislature funds Maine’s share. Other states, such as Idaho and Utah, are keenly watching.
In Maine and Virginia, health care issues played on voters’ minds.
The Trump administration is poised to grant states waivers that some critics say could change the shape of the program.
Funcionarios de salud del presidente Donald Trump podrían diseñar una inscripción más baja, aprobando solicitudes de varios estados republicanos ansiosos por controlar los presupuestos del Medicaid.
Before the Affordable Care Act’s exchanges began, Maine had an “invisible high-risk pool” in place. Republican lawmakers are pointing to it as a success — but it was better funded by a vast margin than the high-risk pools in the House replacement bill.
Investigators claim drugmaker employees met in secret at restaurants, golf outings and at “Girls Night Out” to raise generic drug prices.